Thyroid Disease and the Heart
Abstract
Thyroid hormones have an intimate relationship with cardiac function. Some of the most significant clinical signs and symptoms of thyroid disease are the cardiac manifestations. In both hypothyroidism and hyperthyroidism, the characteristic physiological effects of thyroid hormone can be understood from the actions at the molecular and cellular level. Here we explore topics from the metabolism and cellular effects of thyroid hormone to special considerations related to statin and amiodarone therapy for the alterations in thyroid hormone metabolism that accompany heart disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The positive chronotropic effect of thyroid hormones derives mainly from a direct action of T3 on genes regulating cardiac-pacemaker activity.
“The positive chronotropic effect derives mainly from a direct action of T3 on the genes that regulate the activity of the cardiac-pacemaker.”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
At the cardiac level, stimulation of β-type thyroid-hormone receptors up-regulates calcium-dependent ATPase pumps of the endoplasmic reticulum and reduces expression of Phospholamban, resulting in increased myocardial relaxation and a positive inotropic effect.
“At the cardiac level, stimulation of the β-type thyroid-hormone receptors determines an up-regulation of the calcium-dependent ATPase pumps of the endoplasmic reticulum and a reduced expression of the Phospholamban protein resulting in an inhibitory action.”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
At the peripheral level, stimulation of α-1 thyroid receptors on endothelial and smooth muscle cells reduces peripheral resistance, causing a decrease in diastolic pressure.
“At the peripheral level, the stimulation of the α-1 thyroid receptors, expressed by the endothelial and smooth muscle cells of the vessels, reduces peripheral resistance causing a decrease in diastolic pressure [1, 6].”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
Patients with overt hyperthyroidism experience atrial fibrillation at a rate ranging from 10 to 25%, with higher percentages in males over 60 years and in those with higher free T4 values.
“Patients with overt hyperthyroidism, at a rate ranging from 10 to 25%, experience atrial fibrillation (AF) with even higher percentages in males over 60 years of age and in those with higher free T4 (FT4) values.”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
T3 induces an increase in expression of β1-adrenergic receptors on myocardiocytes, increasing myocardial sensitivity to catecholamines, while simultaneously inhibiting cardiac expression of catalytic isoforms of adenylate-cyclase, keeping the endocellular response unchanged.
“Indeed, T3 induces an increase in the expression of β1-adrenergic receptors on myocardiocytes, increasing myocardial sensitivity to the action of catecholamines, as it simultaneously inhibits the cardiac expression of the catalytic isoforms of adenylate–cyclase, keeping the endocellular response unchanged [1, 6].”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
Only 5% of subjects with thyrotoxicosis under the age of 60 have atrial fibrillation.
“Conversely, only 5% of subjects with thyrotoxicosis under the age of 60 have AF [1, 6].”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
Tachyarrhythmia associated with hemodynamic alterations in hyperthyroidism is often the cause of high-rate heart failure, especially in patients with concomitant risk factors.
“The presence of tachyarrhythmia associated with the previously described hemodynamic alterations is often the cause of high-rate heart failure, especially in patients with concomitant risk factors [1, 6].”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
At the renal level, reduced perfusion from peripheral vasodilation activates the renin-angiotensin-aldosterone system, with sodium-retentive action and increased circulating volume.
“At the renal level, this effect leads to a reduced perfusion with consequent activation of the renin–angiotensin–aldosterone system (to which a direct effect of T3 via thyroid β-1 receptors probably also contributes) with a sodium-retentive action and an increase in circulating volume [1, 6].”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
Thyrotoxicosis determines an imbalance of coagulative homeostasis towards hypercoagulability and reduced fibrinolysis, characterized by increased circulating levels of factor VIII, IX, fibrinogen and Von Willebrand factor.
“thyrotoxicosis determines an imbalance of coagulative homeostasis towards a state of hypercoagulability and reduced fibrinolysis characterized by an increase in the circulating levels of factor VIII, IX, fibrinogen and Von Willebrand factor [1, 6]”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
A role of catecholaminergic stimulation in the positive chronotropic effect of thyroid hormones seems unlikely.
“Although a role of cathecolaminergic stimulation has been hypothesized, this seems unlikely.”
From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [6]
The citation lists haven’t been fetched yet
References 86 · Cited by 218
- Authors
- Klein, I., & Danzi, S.
- Venue
- Current Problems in Cardiology
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 41
- Issue
- 2
- Pages
- 65-92
- ISSN
- 0146-2806 (ISSN-L)
- OpenAlex
- W2180129120
- Cited by
- 218
- References
- 86
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 23 · 2023: 42 · 2022: 24 · 2021: 27 · 2020: 24 · 2019: 27 · 2018: 17 · 2017: 14 · 2016: 3
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Problems in Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- thyroid dysfunction, thyroid hormones, cardiac function, hypothyroidism, hyperthyroidism, thyroid hormone metabolism, statin therapy, amiodarone, heart disease
- MeSH terms
- Amiodarone, Animals, Anti-Arrhythmia Agents, Heart Diseases, Hemodynamics, Humans, Muscle, Smooth, Vascular, Myocardium, Risk Factors, Thyroid Diseases, Thyroid Gland, Thyroid Hormones, Signal Transduction, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review